Jithma P. Abeykoon - Concepedia

Author

Jithma P. Abeykoon

Also Known As

J. Abeykoon, J. P. Abeykoon, Jithma P. Abeykoon, Jithma A. Abeykoon, Jithma Abeykoon, Jithma P Abeykoon, Jithma P. Abeykoon, Jithma Prasad Abeykoon, Jithma  Prasad Abeykoon

286

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Mayo Clinic in Florida WinnMed University of Alabama at Birmingham

About

Jithma P. Abeykoon is an author at Mayo Clinic in Arizona specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	478
2	Health Sciences	5	5	105
3	Cell Biology	3	3	73
4	Biochemistry	1	1	35
5	Biostatistics	1	1	23

Jithma P. Abeykoon

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Ethanol Production from Orange Peels: Two-Stage Hydrolysis and Fermentation Studies Using Optimized Parameters through Experimental Design Harinder Singh Oberoi, Praveen V. Vadlani, Ronald L. Madl, Journal of Agricultural and Food Chemistry	2010	109
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Prashant Kapoor, Journal of Clinical Oncology	2019	96
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia Jonas Paludo, Jithma P. Abeykoon, Amanda Shreders, Annals of Hematology MedicineHematologyPathologyWaldenström MacroglobulinemiaPharmacology	2018	94
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis Jithma P. Abeykoon, Saurabh Zanwar, Angela Dispenzieri, Leukemia RheumatologyAlzheimer's DiseaseSymptomatic TreatmentPharmacotherapyMedicine	2018	82
<i>MYD88</i> mutation status does not impact overall survival in Waldenström macroglobulinemia Jithma P. Abeykoon, Jonas Paludo, Rebecca L. King, American Journal of Hematology	2017	69
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma Xiaosheng Wu, Mary Stenson, Jithma P. Abeykoon, Blood	2019	58
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes Jithma P. Abeykoon, Saurabh Zanwar, Stephen M. Ansell, British Journal of Haematology	2019	49
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia Saurabh Zanwar, Jithma P. Abeykoon, Éric Durot, American Journal of Hematology	2019	49
“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience Iuliana Vaxman, Jithma P. Abeykoon, Angela Dispenzieri, Blood Cancer Journal	2021	48
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on <i>KRAS</i> and <i>MEK</i> Alteration Status Jithma P. Abeykoon, Karen L. Rech, Jason R. Young, JAMA Oncology	2022	44

Page 1